Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma

Journal of Clinical Microbiology

Volumn 38, Issue 12, 2000, Pages 4637-4639

  Tang, Y W ^a   Huong, J T J ^a   Lloyd R M , Jr ^a   Spearman, P ^a   Haas, D W ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; STAVUDINE; VIRUS RNA;

ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS MUTATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034461212     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.12.4637-4639.2000     Document Type: Article

References (19)

1. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy
2. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement
3. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
4. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
5. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
6. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
7. Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma
8. Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting
9. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
10. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
11. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
12. Changing patterns of mortality across Europe in patients infected with HIV-1
13. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
14. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir
15. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: Window into brain infection?
16. Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma
17. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
18. The fastest genome evolution ever described: HIV variation in situ
19. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues